Janet Sasso

Cientista Líder do CAS, Ciências Biológicas

Bio

Janet M. Sasso obteve seu bacharelado em biologia pela The Ohio State University (OSU). Ela também possui mestrado em saúde pública pela OSU, onde concentrou sua pesquisa em equidade e educação em saúde pública. Ela ingressou no CAS em 2006 como Cientista de Informações no departamento de ciências biológicas, curando informações em farmacologia, farmacêutica, ciências ambientais e pesquisa toxicológica. Ela é apaixonada por comunicação científica para acelerar a análise científica e inspirar avanços no mundo todo.

Expressão gênica, editada: Destaques do webinar CAS Insights sobre epigenética

Três especialistas do CAS, da Universidade de Messina e do Instituto Coriell explicam como a epigenética evoluiu de uma área de pesquisa de nicho para uma força clínica, com 13 medicamentos aprovados pela FDA, mais de 2.200 ensaios ativos e um conjunto de ferramentas de diagnóstico em rápido crescimento que está remodelando a forma como detectamos e tratamos o câncer.
|Webinar
Read the CAS Insights article

Point-of-care testing: faster diagnosis, easier access to care

Point-of-care testing goes beyond pandemic-era viral infection tests to bring faster diagnostics for infectious diseases, chronic conditions, cancer, and more.
|Artigo
Read the CAS Insights article

Reading the Circuits: ACS/CAS microelectronics webinar recap

Summary of our recent webinar, featuring experts from CAS, the National Institute of Standards and Technology (NIST), and the University of Manchester, discussing the research landscape of microelectronics research and breakthroughs.
|Webinar
Read the CAS Insights article

Nipah virus explained: Risks, realities, and the hope from new research

New Nipah cases in India have renewed focus on a high‑fatality zoonotic threat shaped by complex spillover dynamics, severe neurological disease, and limited medical countermeasures. Meanwhile, global efforts in diagonistcs, therapeutics, and vaccines are accelerating.
|Artigo
Read the CAS Insights article

Aprimorando a saúde animal com terapias para o microbioma intestinal

Sabemos que o microbioma intestinal é vital para a saúde humana, e novos avanços já estão reduzindo a resistência aos antibióticos e melhorando a saúde geral dos animais.
|Artigo
Read the CAS Insights article

Webinar: pesquisa sobre PFAS, definições e desenvolvimentos regulatórios

De produtos farmacêuticos a semicondutores, os compostos PFAS estão por toda parte. Esta recapitulação do webinar da ACS/CAS explora como a evolução das definições estruturais está mudando o cenário regulatório e o que isso significa para a ciência, as políticas e a inovação.
|Artigo
Read the CAS Insights article

O futuro da administração de medicamentos à base de lipídios

Resumo do webinar sobre o cenário de administração de medicamentos à base de lipídios
|Webinar
Read the CAS Insights article

Webinar: Tendências da ciência dos materiais a observar em 2025

Ouça o que os principais especialistas dizem sobre as tendências da ciência dos materiais para 2025
|Webinar
Read the CAS Insights article
Woman participating in a virtual meeting at her desk, viewing four speakers discussing on a video call with CAS and Polaris logos visible on the screen.

Webinar: Avanços científicos e tendências emergentes para acompanhar em 2025

Confira as opiniões de diversos especialistas sobre as tendências científicas a serem observadas em 2025.
|Webinar
Read the CAS Insights article

Healthy longevity: Aging hallmarks and strategies

Experts from CAS, Harvard Medical School, Procter & Gamble, and Cedars-Sinai Medical Center discuss health aging research.
|Webinar
Read the CAS Insights article

Latest developments in the global mpox outbreak

With recent headlines on monkeypox, learn more about the research landscape, scientific profiles, and currently available therapies. A deeper understanding of the published science enables clarity and insight on this emerging news story.
|Artigo
Read the CAS Insights article

Webinar: Emerging areas in biomaterials - Reshaping medicine and human health

Biomaterials are making an impact on health and medicine. Experts from CAS, Ortholevo, and Westlake University discuss the full landscape.
|Webinar
Read the CAS Insights article

Doenças raras e doenças órfãs: a terapia combinada pode tratá-las?

Como as terapias combinadas, incluindo reaproveitamento de medicamentos, terapia celular e terapia genética, estão levando a um melhor tratamento de doenças raras.
|Artigo
Read the CAS Insights article

Decoding neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's

Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
|Relatório de insights
Read the CAS Insights article

Webinar: Scientific breakthroughs and emerging trends to watch in 2024

Experts from Lawrence Livermore National Lab, Oak Ridge National Lab, The Ohio State University, and CAS discuss major research trends in 2024.
|Webinar
Read the CAS Insights article

Biomarkers: The key to earlier cancer detection and patient outcomes

CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
|Relatório de insights
Read the CAS Insights article

How biomarkers unlock faster cancer detection, improving outcomes

As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
|Artigo
Read the CAS Insights article

Unveiling the potential of the antibody drug conjugate

Since 2018, research interest in antibody-drug conjugates has increased exponentially, due to their potential in the fight against cancer.
|Artigo
Read the CAS Insights article

Webinar on gut microbiome-brain alliance: The connection to health and disorders

CAS, Bayer, and Caltech explore how the gut-brain axis influences health from IBS to autism.
|Webinar
Read the CAS Insights article

Aging reimagined: Exploring the potential of anti-aging treatment strategies

Discover the latest in anti-aging treatment strategies to promote health and longevity, including stem cell therapies, hyaluronic acid, senolytics, gene therapy, and more.
|Artigo
Read the CAS Insights article

Webinar on nature’s lipid nanoparticles: Exosomes

Exosomes have enormous potential in drug delivery, diagnostics, and more. Mayo Clinic, Direct Biologics, and Aruna Bio discuss the full landscape.
|Webinar
Read the CAS Insights article

Exosome research: from platelet dust to pioneering therapeutics

Landscape view of emerging contributors, companies, and researchers in the emerging field of exosome research. This article overviews key players in diagnostics and therapeutic fields of exosome research with a deeper look into the current clinical pipeline.
|Artigo
Read the CAS Insights article

ACS webinar on molecular glues and targeted protein degradation

Expert panelists include Dr. Benjamin Ebert, the chair of Medical Oncology at the Dana-Farber Institute, Dr. Phil Chamberlain, the co-founder, President, and CEO of Neomorph, and Janet Sasso, an information scientist specializing in Life Sciences at CAS.
|Webinar
Read the CAS Insights article

Why the omicron BA.5 variant evades vaccines

As COVID-19 cases rise again worldwide, the Omicron subvariant BA.5 is currently the dominant strain. This blog explores some key mutations that increase transmission, evade protective antibodies, and increase the rate of (re)infection.
|Artigo
Read the CAS Insights article

Molecular glues tackle undruggable targets

Molecular glues have been used to uncover new therapeutic agents. Because of their targeted protein degradation that holds them together, these glues have exciting potential in uncovering new drugs to fight cancer, immune diseases, and more.
|Artigo
Read the CAS Insights article

A therapeutic revolution: RNA in COVID-19 and beyond

We are in the midst of a therapeutic revolution, according to the authors of a recent review article in Frontiers in Bioengineering and Biotechnology.
|Artigo
Read the CAS Insights article

COVID-19 vaccine boosters: what does the research show?

With recent mRNA booster recommendations, many ask if they should get a COVID-19 booster and what the science shows? This blog explains the science of boosters, reviews current recommendations, and examines recent research.
|Artigo
Read the CAS Insights article